|
Volumn 20, Issue 6, 2000, Pages 615-621
|
Therapeutic effects of imipramine are counteracted by its metabolite, desipramine, in patients with generalized anxiety disorder
a a b a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
DESIPRAMINE;
IMIPRAMINE;
NORADRENALIN;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
ANTICHOLINERGIC EFFECT;
ANXIETY NEUROSIS;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG INHIBITION;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RATING SCALE;
TREATMENT OUTCOME;
VAGUS TONE;
ADRENERGIC UPTAKE INHIBITORS;
ADULT;
ANXIETY DISORDERS;
ARRHYTHMIA, SINUS;
BLOOD PRESSURE;
DESIPRAMINE;
DRUG INTERACTIONS;
FEMALE;
HEART RATE;
HUMANS;
IMIPRAMINE;
LINEAR MODELS;
MALE;
MIDDLE AGED;
PSYCHIATRIC STATUS RATING SCALES;
|
EID: 0033697738
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200012000-00006 Document Type: Article |
Times cited : (20)
|
References (24)
|